Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma(JCOG0110, GCSSG-SPNX)

Phase 3

• Conditions: T2, T3, and T4 carcinoma in the proximal third of the stomach

• Registration Number: JPRN-C000000004
• Lead Sponsor: Japan Clinical Oncology Group(JCOG)

Brief Summary

See the datails via "URL releasing results" above. Also the details can be seen in the JCOG website: http://www.jcog.jp/en/trials/index.html

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-06-07
• Study Completion: 2014-07-01
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 500

Inclusion Criteria

Not provided

Exclusion Criteria

(1) Liver cirrhosis or portal hypertension (2) idiopathic thrombocytopenic purpura (3) severe pulmonary dysfunction (4)synchronous or metachronous (within 5 years) malignancy

Study & Design

• Study Type: Interventional
• Study Design: Not specified